EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a ...

The Democratic Republic of Congo, the epicenter of an mpox outbreak, on Thursday, received its first vaccines — almost half ...

The resurgence of mpox during 2024 has been declared a continental emergency by the Africa Centres for Disease Control and Prevention (Africa CDC) and a Public Health Emergency of International ...

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

UNICEF and partners are scaling up the emergency response in the DRC, Burundi and other countries in Africa, but more donor ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

African health-care workers fighting the rapid spread of a virulent mpox strain will learn how to effectively scratch under ...

NIH Releases Mpox Research Agenda - Plan will Advance Knowledge of Virus Biology to Improve Detection, Treatment and Prevention ...

Several hundred high-risk individuals were inoculated in Rwanda. Meanwhile, the Africa Centres for Disease Control and Prevention warned that the outbreak in Africa is still not under control, with ...